← All Sponsors
SPONSOR

JHM BioPharma (Tonghua) Co. , Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Moderate to Severe Glabellar Lines
NCT06937944 Phase 3
Recruiting

Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines
China View Trial →